Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01766011 · ClinicalTrials.gov registry record · Phase 2
Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital
A Phase 2 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT01766011 is a Phase 2 study that has completed, run by Abbott Nutrition. The registered enrollment target is 28 participants.
The verdict
NCT01766011, a Phase 2 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to assess overall growth of preterm infants fed a reformulated preterm infant formula during hospitalization. All study products meet levels of nutrients for the infant population as specified in the Infant Formula Act and all subsequent amendments.
Interventions
- OTHER study pre-term formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01766011
The ClinicalTrials.gov registry entry for NCT01766011 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which study pre-term formula is the first listed.
NCT01766011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01766011 about?
NCT01766011 is a clinical study titled "Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital". The purpose of this study is to assess overall growth of preterm infants fed a reformulated preterm infant formula during hospitalization. All study products meet levels of nutrients for the infant population as specified in the Infant Formula Act and all subsequent amendments.
What is the current status of trial NCT01766011?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2012-11. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01766011?
The interventions under investigation include: study pre-term formula (OTHER).
Who is sponsoring clinical trial NCT01766011?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.